nancyshapira's posterous

BiondVax enters into Term Sheet to secure up to $ 7 Million with Yorkville Advisors

Biondvax  is an Israeli biopharmaceutical company at the forefront of the development
of a Universal Influenza Vaccinehttp://www.biondvax.com/128084/News---Media-1
To Posterous, Love Metalab